louisiana glp-1 intestinal paralysis legal team Ozempic Lawyer What Gastrointestinal Side Effects Qualify
Description
$8B GLP-1 Genetic Market by 2030 (Nomura projection) 3
While Wegovy and Zepbound added non-weight-loss indications, this second payer, instead, moved to outright rejecting claims between 70% and 80% of the time
GLP-Pro pairs pasteurized Akkermansia, ButyraGen and resilient Bacillus spores to nourish L-cellsthe gut messengers that naturally release GLP-1while reinforcing the intestinal barrier and short-chain fatty-acid output for balanced appetite cues, comfortable digestion and everyday metabolic wellness.*
A new BakeryAndSnacks article makes the picture very clear
This article breaks down the costs associated with GLP-1 drugs and what to consider
